Self-Guided CBT for Eczema, Zepbound for Sleep Apnea, and AI in Diabetes Detection

In this episode, Dr. Chi-Ming Chow introduces self-guided cognitive behavioral therapy (CBT) for eczema, discussing its efficacy, benefits, and insights from recent trials. He analyzes the FDA's approval of Zepbound for obstructive sleep apnea, evaluating its potential impact on treatment options. The episode offers personal growth and coping strategies for individuals spending Christmas alone, emphasizing emotional well-being. Dr. Chow examines London's AI trials aimed at predicting type 2 diabetes and enhancing early detection efforts. The episode concludes with remarks on the transformative potential of AI in healthcare.